Drug-coated Balloon
15
3
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (15)
STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
Effect of Enhanced External Counterpulsation
Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion
Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
Drug-coated Balloon Treatment in Coronary Lesions
Prevail Drug Balloon Study
Bingo Drug-Coated Balloon in Real World
Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions
DCB Angioplasty for Coronary Lesions: an OCT Analysis
Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database
DCB in de Novo Coronary Lesion
DCB for Dialysis Access Stent Graft Restenosis